Aquatic Capital Management LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1803916 CHICAGO, IL

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,948,657

+$2,048,897 QoQ

Shares Held

97,897

+139.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $20,937,777 across 21 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	140,331	$5,296,091
2	TEVA	Teva Pharmaceutical Industries Ltd This page	97,897	$2,948,657
3	TAK	Takeda Pharmaceutical Co Ltd	153,759	$2,847,616
4	RDY	Dr Reddys Laboratories Ltd	198,046	$2,742,937
5	ZTS	Zoetis Inc.	16,038	$1,895,851
6	VTRS	Viatris Inc	99,833	$1,348,743
7	NBIX	Neurocrine Biosciences Inc	6,375	$839,842
8	AQST	Aquestive Therapeutics, Inc.	141,350	$586,602

All Filings in TEVA

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,948,657	97,897	+139.8%	Shares	Sole	2026-05-15
2024-12-31	$899,760	40,824	-83.9%	Shares	Sole	2025-02-14
2024-09-30	$4,559,060	253,000	+7.9%	Shares	Sole	2024-11-14
2024-06-30	$3,809,000	234,400	+398.7%	Shares	Sole	2024-08-14
2024-03-31	$663,170	47,000	+253.4%	Shares	Sole	2024-05-15
2023-12-31	$138,852	13,300	-84.7%	Shares	Sole	2024-02-14
2023-06-30	$656,616	87,200	-33.1%	Shares	Sole	2023-08-14
2023-03-31	$1,153,155	130,300	+126.6%	Shares	Sole	2023-05-15
2022-06-30	$432,400	57,500	+9.7%	Shares	Sole	2022-08-15
2021-12-31	$419,724	52,400	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.